KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other financing activities: 2016-2019

  • BeOne Medicines' Other financing activities was N/A to $4.0 million in Q2 2019 from the same period last year, while for Jun 2019 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q2 2019, BeOne Medicines' Other financing activities is $4.0 million, which was up 1,066.18% from -$414,000 recorded in Q4 2018.
  • In the past 5 years, BeOne Medicines' Other financing activities registered a high of $4.0 million during Q2 2019, and its lowest value of -$414,000 during Q4 2018.
  • Its 2-year average for Other financing activities is $1.3 million, with a median of $414,000 in 2018.